Maimonides' holiday party brings comfort and cheer to pediatric patients * Brooklyn PaperMaimonides Medical Center's holiday party enables pediatric patients to experience joy and normalcy, emphasizing the importance of mental well-being during treatment.
The First Crispr Treatment Is Making Its Way to PatientsThe first CRISPR-based treatment, Casgevy, has been approved for sickle cell disease and beta thalassemia, marking a significant advance in gene-editing therapies.
Gene Therapies Could Transform Treatment of Rare Blood Disorders - News CenterGene therapy shows promising results in treating rare genetic blood disorders like beta thalassemia and sickle cell disease.
The First Crispr Treatment Is Making Its Way to PatientsThe first CRISPR-based treatment, Casgevy, has been approved for sickle cell disease and beta thalassemia, marking a significant advance in gene-editing therapies.
Gene Therapies Could Transform Treatment of Rare Blood Disorders - News CenterGene therapy shows promising results in treating rare genetic blood disorders like beta thalassemia and sickle cell disease.